ABY025
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABY025, covering 2013-04-15 to 2013-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of Breast Cancer With ABY025 [Phase 1, Phase 2]